Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-beach crawled time : 14:30 save search
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
DXCM | $137.86 2.88% 2.8% 3.2M
|
Health Technology
|
| O: -1.17%
H: 1.22%
C: 0.23%
first conference
Biological Dynamics Announces Expanding Adoption of ExoVerita™ Pro Under Early Access Program
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
pro program
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update
Published: 2024-03-13 (Crawled : 14:30) - biospace.com/
AADI | $1.79 -2.72% -2.79% 110K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: 0.0%
bioscience update financial results
Kiora Announces Publication of Phase 1 Study Demonstrating Safety, Tolerability and Anti-Inflammatory Activity of KIO-101 in the Treatment of Inflammation of the Eye
Published: 2024-03-08 (Crawled : 14:30) - biospace.com/
KPRX | $0.504 -13.03% -14.98% 290K
|
Manufacturing
|
| O: 2.4%
H: 2.64%
C: -4.18%
kio-101 publication treatment eye study
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
NVNO | $5.27 -4.18% -4.36% 100K
|
Manufacturing
|
| O: 2.96%
H: 3.48%
C: -9.7%
enous2024 positive topline meeting trial today
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
Published: 2024-02-26 (Crawled : 14:30) - biospace.com/
TBIO | $0.311 -3.86% -4.02% 130K
|
Health Technology
|
| O: -16.18%
H: 16.09%
C: 0.95%
financial results
Modular Medical Announces Issuance of New US Patent
Published: 2024-01-24 (Crawled : 14:30) - biospace.com/
MODD 4 | $1.55 -1.27% -1.29% 36K
|
|
| O: -1.55%
H: 4.74%
C: 1.05%
patent medical
Ainos Announces $1.75 Million Follow-On Funding
Published: 2024-01-24 (Crawled : 14:30) - biospace.com/
AIMD | $1.03 0.98% 0.97% 50K
|
Manufacturing
|
| O: -2.59%
H: 5.31%
C: -7.96%
million funding
Ainos, Inc. Announces Stock Consolidation
Published: 2023-12-12 (Crawled : 14:30) - biospace.com/
AIMD | $1.03 0.98% 0.97% 50K
|
Manufacturing
|
| O: -3.28%
H: 3.49%
C: -0.91%
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc.
Published: 2023-12-12 (Crawled : 14:30) - biospace.com/
ADTX | $2.27 2.84% 27K
|
Health Technology
|
| O: 84.99%
H: 35.14%
C: -13.37%
acquire agreement
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023
Published: 2023-12-05 (Crawled : 14:30) - biospace.com/
RGBP | $0.7 5.69% 1.5K
|
Manufacturing
|
| O: -3.39%
H: 4.39%
C: 1.75%
conference growth
Melinta Therapeutics & Cidara Therapeutics Announce Publication of Pooled Data from Phase 3 Pivotal ReSTORE Trial
Published: 2023-12-05 (Crawled : 14:30) - biospace.com/
CDTX | News | $11.94 16.49% 14.15% 170K
|
Health Technology
|
| O: 1.07%
H: 6.26%
C: 1.08%
publication trial therapeutics
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement
Published: 2023-12-05 (Crawled : 14:30) - biospace.com/
KTRA | $0.1374 3.54% 3.42% 5.8M
|
Distribution Services
|
| O: 6.58%
H: 0.0%
C: -16.18%
nasdaq granted extension therapeutics
Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-032, for the Treatment of Cystic Fibrosis
Published: 2023-11-27 (Crawled : 14:30) - biospace.com/
ARCT 4 | $27.0 -3.33% -3.44% 270K
|
Health Technology
|
| O: 2.89%
H: 6.75%
C: 4.88%
arct-032 fda drug treatment fibrosis designation therapeutics
MEI Pharma to Present at the Stifel 2023 Healthcare Conference
Published: 2023-11-08 (Crawled : 14:30) - biospace.com/
MEIP | $3.26 -2.17% -2.22% 7.4K
|
Health Technology
|
| O: -0.8%
H: 2.03%
C: -2.43%
pharma conference
Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023
Published: 2023-09-27 (Crawled : 14:30) - biospace.com/
QLGN | $0.296 -6.03% -6.42% 24K
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: -1.9%
qn-302 cancer pancreatic therapeutics
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire
Published: 2023-09-27 (Crawled : 14:30) - biospace.com/
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: -2.28%
H: 0.0%
C: 0.0%
phexxi fda approval market
AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson’s Disease
Published: 2023-09-12 (Crawled : 14:30) - biospace.com/
AXIM | $0.0109 -6.67% 1.1M
|
Manufacturing
|
| O: 11.06%
H: 0.0%
C: -1.53%
axim disease test diagnostic parkinson’s
FIGS and Eko Health Collaborate on the FIGS | Eko CORE 500™ Digital Stethoscope
Published: 2023-09-05 (Crawled : 14:30) - biospace.com/
FIGS | $4.82 0.63% 0.0% 2.4M
|
Manufacturing
|
| O: -1.13%
H: 2.6%
C: -0.16%
health
David Topper Joined Inmagene as CFO
Published: 2023-09-05 (Crawled : 14:30) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 0.01%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.